Loading...
XWAR
SNT
Market cap503mUSD
May 22, Last price  
222.40PLN
1D
0.54%
1Q
-1.81%
Jan 2017
1,308.49%
IPO
2,635.55%
Name

Synektik SA

Chart & Performance

D1W1MN
P/E
22.41
P/S
3.04
EPS
9.92
Div Yield, %
1.36%
Shrs. gr., 5y
—
Rev. gr., 5y
35.87%
Revenues
624m
+39.66%
31,026,57145,077,18261,451,51277,375,82778,693,40683,598,41749,433,13662,936,490105,323,138134,786,623125,386,200128,627,450166,860,941446,871,567624,121,793
Net income
85m
+61.36%
1,063,660008,244,2983,604,8050388,0914,085,13010,293,4369,136,2958,810,1348,383,81010,301,20652,452,19084,636,220
CFO
90m
-5.17%
07,150,8912,666,7686,431,59211,962,2635,722,563014,571,6405,224,43813,547,20313,927,83821,710,302094,493,46389,609,373
Dividend
Mar 01, 20243.03 PLN/sh
Earnings
Jun 09, 2025

Profile

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology. It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests. Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.
URL
https://www.synektik.com.pl/
IPO date
Aug 09, 2011
Employees
151
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑122016‑122015‑12
Income
Revenues
624,122
39.66%
446,872
167.81%
166,861
29.72%
Cost of revenue
500,573
377,605
156,846
Unusual Expense (Income)
NOPBT
123,548
69,267
10,015
NOPBT Margin
19.80%
15.50%
6.00%
Operating Taxes
21,342
13,223
1,988
Tax Rate
17.27%
19.09%
19.85%
NOPAT
102,206
56,044
8,027
Net income
84,636
61.36%
52,452
409.18%
10,301
22.87%
Dividends
(5,117)
(3,838)
Dividend yield
0.99%
1.62%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,321
4,873
23,670
Long-term debt
43,660
31,269
28,223
Deferred revenue
1
Other long-term liabilities
23,755
26,908
22,916
Net debt
(39,151)
(28,047)
40,810
Cash flow
Cash from operating activities
89,609
94,493
CAPEX
(9,685)
Cash from investing activities
(11,547)
Cash from financing activities
(33,173)
(31,596)
2,143
FCF
70,827
68,168
(10,958)
Balance
Cash
84,332
63,466
10,857
Long term investments
3,800
724
227
Excess cash
56,926
41,846
2,740
Stockholders' equity
129,976
74,625
87,165
Invested Capital
180,964
137,984
143,833
ROIC
64.09%
39.77%
6.81%
ROCE
50.49%
37.13%
6.50%
EV
Common stock shares outstanding
8,529
8,529
8,529
Price
191.80
216.50%
60.60
117.59%
27.85
-5.91%
Market cap
1,635,887
216.50%
516,865
117.59%
237,536
-5.91%
EV
1,596,736
488,818
278,346
EBITDA
140,082
84,048
22,054
EV/EBITDA
11.40
5.82
12.62
Interest
1,443
1,903
1,456
Interest/NOPBT
1.17%
2.75%
14.54%